Stretch Marks Treatment Market Trends

Growth Drivers  

• Surge in prevalence of the maternal and post-weight gain cohorts: The Centers for Disease Control and Prevention stated that 51-90% of women with pregnancy witness the appearance of striae gravidarum. Most of the women are affected, making a huge demand for treatment during and after the pregnancy. Women are seeking treatment numerous times, that is, during pregnancy, after weight gain, and post-pregnancy. There has been a growth in the acceptance and awareness of cosmetic treatments, which has increased the willingness to opt for these treatments. There is an expanding consumer base, showing the sustained growth of the market.
• Government spending and reimbursement policies: In 2023, the government in the U.S. spent USD 1.23 billion on cosmetic and dermatological treatments. Also, the clearance from the FDA of various retinoid-based creams for the treatment of early-stage stretch marks has expanded in the last few years. The surge in Medicare coverage for the medically necessary stretch mark treatments is driving the market growth by 11-16% annually. Various cutting-edge procedures, such as radiofrequency lasers, CO2 lasers, etc., are standardized and usually offered via clinics under health plans.
• Technological advancements: The stem cell therapy in the treatment of stretch marks is a burgeoning field in aesthetic dermatology. The technology aims to enhance elasticity, skin regeneration, and the production of collagen. In 2024, BellaSeno GmbH trial showed 51% improvement in severe stretch mark conditions with the usage of autologous stem cell therapy. Also, Korea’s Raphas Co. has launched dissolvable microneedle patches consisting of hyaluronic acid, lowering treatment time by 41%. There has been a huge demand for non-invasive treatments over various clinical procedures.

Regional growth trajectories across eight foundational markets:

Revenue Feasibility Models for Stretch Marks Treatment (2022–2024)

Challenges

• The government-imposed price control: In the EU and Canada market, the products and services associated with the stretch mark treatment are put through restricted price flexibility and reference pricing. In 2023, a cosmeceutical firm in Germany registered a 15.4% drop in revenue owing to the mandatory public insurance price caps.
• Delayed regulatory approval timelines and exorbitant out-of-pocket costs: In a plenty of countries, compliance holp up pose issues due to strict clinical requirements and data regulatory strategies. For instance, in 2022, the adoption of novel ingredients for post-pregnancy treatment was pushed back by 6 months under the Pharmaceuticals and Medical Devices Agency in Japan.